Home ⟩ Insights

Insights

21

New Jersey Cannabis panel

4 min read • February 26, 2026

Margin Percent Isn’t The Point Anymore: “Dollars In My Pocket” Takes Over

The Plant Matters

5 min read • February 24, 2026

New Jersey Growers Say Genetics, Terpenes and Craft Cultivation Will Define the Next Phase of the Market

cannabis Germany

3 min read • February 24, 2026

Organigram Moves Into Europe With Proposed Acquisition of Germany’s Sanity Group

The Maryland State House

4 min read • February 23, 2026

Maryland Bill Targets Capital Bottlenecks Facing Social Equity Cannabis Operators

NJCRC at IgniteIt Market Spotlight

4 min read • February 23, 2026

New Jersey Regulators Outline the Next Phase of a Fair and Stable Cannabis Market

Whoopi Goldberg

5 min read • February 20, 2026

Exclusive – Whoopi Goldberg: ‘I’m 70. I Like Pleasure.’ The Cannabis Conversation on Aging

Jason Wild and Tim Seymour

3 min read • February 19, 2026

When Will Marijuana Be Rescheduled? This Cannabis Veteran Says Industry Is ‘Getting Close’

IgniteIt New Jersey Market Spotlight

4 min read • February 18, 2026

Cannabis Insiders Say Federal Reform Is a Tailwind, Not a Lifeline

13 min read • February 17, 2026

Pleasure, Not Fear: The Drug Policy Shift That Could Save Billions

3 min read • February 17, 2026

The Case For Low Dose As The Mass Market

3 min read • February 17, 2026

Cornbread Hemp Adds Lagunitas Brewing Veterans To Advise Expansion of Beverage Operations

edibles.com_Portfolio_of_brands

4 min read • February 16, 2026

Chicago Mayor Vetoes City Ban on Hemp THC Products

Latest Headlines

3 min read • April 30, 2026

Cannabis Earnings Show How Verano and SNDL Are Navigating Margin Pressure, Pricing, and Uneven Demand

3 min read • April 30, 2026

Medical Cannabis Operators Face New Federal Compliance Costs as Schedule III Shift Advances

2 min read • April 29, 2026

This Southern State Is Still an Untapped Cannabis Market As Lawmakers Revisit Medical Marijuana Policy

3 min read • April 29, 2026

Vext Science Cannabis Co. Boosts Cash Flow 256% YoY, Margins Grow in 2025 Ahead of Ohio Push

3 min read • April 29, 2026

New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development

4 min read • April 28, 2026

Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

3 min read • April 28, 2026

This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know

2 min read • April 28, 2026

TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop

4 min read • April 27, 2026

DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know

4 min read • April 27, 2026

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

4 min read • April 27, 2026

EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan

min read • April 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.